Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Ginkgo Bioworks Holdings, Inc. (DNA) Institutional Ownership & Insider Trading

183 institutions reported holding Ginkgo Bioworks Holdings, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 26 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

DNAGinkgo Bioworks Holdings, Inc.Follow DNA — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
672.7M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

183 institutions held 53.7% of the shares. Across filers that reported both quarters, shares held changed +12.0%.

Increased+68New+25Decreased-36Closed-14

Largest moves, shares (millions)

BlackRock+0.6MErste Asset Management GmbH+0.6MRenaissance Technologies+0.4MGoldman Sachs Group-0.3MMorgan Stanley-0.3MJacobs Levy Equity…-0.3M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
+0.0Sep 24+5.9Dec 24-0.2Mar 25+1.1Jun 25-2.8Sep 25+2.2Dec 25-0.1Mar 26+3.9Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2618336+12.0%68253614
Mar 2617332-0.5%50214123
Dec 2517733+7.1%45264021
Sep 2516930-8.5%43233719
Jun 2516533+3.3%44303328
Mar 2516532-0.8%47272825
Dec 2416533+22.6%40313320
Sep 2414626—————

Ginkgo Bioworks Holdings, Inc. — questions

Who owns Ginkgo Bioworks Holdings, Inc. stock?
183 institutions reported Ginkgo Bioworks Holdings, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (6.4%), VIKING GLOBAL INVESTORS LP (5.3%), Erste Asset Management GmbH (3.8%).
Are Ginkgo Bioworks Holdings, Inc. insiders buying or selling?
26 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Ginkgo Bioworks Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.